Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2015138354 |
Title |
Combination Therapy for Head and Neck Cancer. |
Abstract |
This invention relates to pharmaceutical composition and methods of using RXR agonist and/or RAR agonist for the treatment or prevention of head and neck cancer. |
Applicant(s) |
Cornell University |
Representative Drug(s) |
D0ZQ0X |
Drug Info
|
N.A. |
[1] |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US20140303223 |
Title |
Composition and Method for Muscle Repair and Regeneration. |
Representative Drug(s) |
D09YFJ |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0W8JK
|
Drug Info
|
N.A.
|
[1] |
3
|
D0YP0T
|
Drug Info
|
N.A.
|
[1] |
4
|
D0ZQ0X
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20150190372 |
Title |
Microcapsules Containing Retinoids, Method of Preparing Same, and Pharmaceutical Compositions Containing Same. |
Patent ID |
US20150150974 |
Title |
Aqueous-Gel-Type Topical Compositions In The form of A Homogenous Suspension of An Active Principle of The Class of Retinoids Containing At Least One Hydrophobic Silica. |
Patent ID |
US20150147403 |
Title |
Dermatological Composition Comprising Oleosomes and Retinoids, Process for Preparing The Same and Use Thereof. |
Patent ID |
US20140275049 |
Title |
Substituted Pyrazole Analogues As Rar Antagonists. |
Patent ID |
US20140194517 |
Title |
Treatment of Graft-Versus-Host Disease Disorders Using Rar Antagonists. |
European Patent Office (EPO) |
Patent ID |
EP2918290 |
Title |
Therapeutic Agent for Keratoconjunctive Disorders. |
Representative Drug(s) |
D01OYE |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09YFJ
|
Drug Info
|
N.A.
|
[1] |
3
|
D0MC3J
|
Drug Info
|
N.A.
|
[1] |